The Supreme Court is set to hear oral arguments Tuesday in a case that could have far-reaching effects on access to the abortion pill mifepristone.
Why it matters: Not only could the court's decision further curtail abortion access across the country, but it could also have wider implications for the Food and Drug Administration's regulatory authority.
